Thomas Braun founded Verisante Technologies Inc. in 2006 and is president and CEO of the company, which went public in 2009 on the TSX Venture Exchange and acquired the exclusive worldwide rights to an award-winning, innovative cancer detection technology developed by the BC Cancer Agency. The two key products licensed by the company are the Verisante Aura for skin cancer detection and the Verisante Core for lung, colon and cervical cancer detection. Braun has led the company through subsequent financings and negotiated agreements and patent acquisitions that have resulted in Verisante becoming a leader in developing cancer detection systems. The company has also secured approvals for the Aura in Canada, Europe and Australia. Previously, Braun practiced corporate securities law at his law firm, Braun and Co., representing high-tech startups. His practice included technology licensing, corporate law and securities law. Braun earned a bachelor's degree from Western University, a juris doctor degree from the University of British Columbia and a master of laws degree from the University of San Francisco, specializing in international business transactions. He is a member of the State Bar of California, and the Law Society of British Columbia. Braun is married with four children, and has lived in Vancouver since 1977.